| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 6.44e-07 | 22 | 16 | 3 | GO:0003756 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 6.44e-07 | 22 | 16 | 3 | GO:0016864 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 1.20e-05 | 57 | 16 | 3 | GO:0016860 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase activity | 3.73e-04 | 36 | 16 | 2 | GO:0015035 | |
| GeneOntologyMolecularFunction | isomerase activity | 4.47e-04 | 192 | 16 | 3 | GO:0016853 | |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 5.33e-04 | 43 | 16 | 2 | GO:0015036 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors | 9.36e-04 | 57 | 16 | 2 | GO:0016667 | |
| GeneOntologyMolecularFunction | integrin binding | 8.45e-03 | 175 | 16 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.43e-02 | 230 | 16 | 2 | GO:0005516 | |
| GeneOntologyBiologicalProcess | protein folding in endoplasmic reticulum | 4.96e-05 | 13 | 17 | 2 | GO:0034975 | |
| GeneOntologyBiologicalProcess | neuronal stem cell population maintenance | 2.05e-04 | 26 | 17 | 2 | GO:0097150 | |
| GeneOntologyCellularComponent | pericentriolar material | 2.32e-04 | 28 | 17 | 2 | GO:0000242 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.29e-03 | 332 | 17 | 3 | GO:0005788 | |
| HumanPheno | Abnormality of the larynx | 3.77e-05 | 666 | 5 | 5 | HP:0001600 | |
| HumanPheno | Cachexia | 7.14e-05 | 100 | 5 | 3 | HP:0004326 | |
| HumanPheno | Generalized muscle weakness | 1.71e-04 | 134 | 5 | 3 | HP:0003324 | |
| HumanPheno | Foot dorsiflexor weakness | 2.12e-04 | 144 | 5 | 3 | HP:0009027 | |
| HumanPheno | Abnormality of the foot musculature | 2.44e-04 | 151 | 5 | 3 | HP:0001436 | |
| HumanPheno | Proximal muscle weakness in lower limbs | 4.54e-04 | 186 | 5 | 3 | HP:0008994 | |
| HumanPheno | Abnormality of the upper respiratory tract | 4.90e-04 | 1111 | 5 | 5 | HP:0002087 | |
| HumanPheno | Progressive distal muscular atrophy | 5.34e-04 | 38 | 5 | 2 | HP:0008955 | |
| HumanPheno | Abnormality of the voice | 5.94e-04 | 545 | 5 | 4 | HP:0001608 | |
| HumanPheno | Jaw hyperreflexia | 6.23e-04 | 41 | 5 | 2 | HP:0033683 | |
| HumanPheno | Fatigable weakness of swallowing muscles | 6.53e-04 | 42 | 5 | 2 | HP:0030195 | |
| HumanPheno | Laryngospasm | 6.53e-04 | 42 | 5 | 2 | HP:0025425 | |
| HumanPheno | Hoffmann sign | 7.84e-04 | 46 | 5 | 2 | HP:0031993 | |
| HumanPheno | Abnormally high-pitched voice | 8.19e-04 | 47 | 5 | 2 | HP:0001620 | |
| HumanPheno | Abnormal larynx physiology | 8.54e-04 | 48 | 5 | 2 | HP:0025424 | |
| HumanPheno | Amyotrophic lateral sclerosis | 8.90e-04 | 49 | 5 | 2 | HP:0007354 | |
| HumanPheno | Frontotemporal dementia | 1.00e-03 | 52 | 5 | 2 | HP:0002145 | |
| HumanPheno | Tongue atrophy | 1.00e-03 | 52 | 5 | 2 | HP:0012473 | |
| HumanPheno | Lower limb muscle weakness | 1.01e-03 | 244 | 5 | 3 | HP:0007340 | |
| HumanPheno | Xerostomia | 1.12e-03 | 55 | 5 | 2 | HP:0000217 | |
| HumanPheno | Respiratory failure | 1.25e-03 | 262 | 5 | 3 | HP:0002878 | |
| HumanPheno | Fatigable weakness of respiratory muscles | 1.25e-03 | 58 | 5 | 2 | HP:0030196 | |
| HumanPheno | Abnormal pitch | 1.33e-03 | 60 | 5 | 2 | HP:5200005 | |
| HumanPheno | Fatigable weakness of bulbar muscles | 1.38e-03 | 61 | 5 | 2 | HP:0030192 | |
| HumanPheno | Motor neuron atrophy | 1.61e-03 | 66 | 5 | 2 | HP:0007373 | |
| HumanPheno | Abnormal Intonation | 1.76e-03 | 69 | 5 | 2 | HP:5200010 | |
| HumanPheno | Abnormality of the musculature of the lower limbs | 1.80e-03 | 297 | 5 | 3 | HP:0001437 | |
| HumanPheno | Tongue fasciculations | 2.02e-03 | 74 | 5 | 2 | HP:0001308 | |
| HumanPheno | Bowing of the long bones | 2.15e-03 | 316 | 5 | 3 | HP:0006487 | |
| HumanPheno | Anomaly of the limb diaphyses | 2.27e-03 | 322 | 5 | 3 | HP:0006504 | |
| Domain | THIOREDOXIN_1 | 1.42e-06 | 25 | 17 | 3 | PS00194 | |
| Domain | Thioredoxin | 2.77e-06 | 31 | 17 | 3 | PF00085 | |
| Domain | Prot_disulphide_isomerase | 4.67e-06 | 4 | 17 | 2 | IPR005792 | |
| Domain | Thioredoxin_domain | 6.54e-06 | 41 | 17 | 3 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 7.56e-06 | 43 | 17 | 3 | PS51352 | |
| Domain | ER_TARGET | 9.91e-06 | 47 | 17 | 3 | PS00014 | |
| Domain | Disulphide_isomerase | 2.18e-05 | 8 | 17 | 2 | IPR005788 | |
| Domain | Thioredoxin | 6.05e-05 | 13 | 17 | 2 | IPR005746 | |
| Domain | Thioredoxin_CS | 1.05e-04 | 17 | 17 | 2 | IPR017937 | |
| Domain | - | 1.73e-04 | 122 | 17 | 3 | 3.40.30.10 | |
| Domain | Thioredoxin-like_fold | 2.18e-04 | 132 | 17 | 3 | IPR012336 | |
| Pubmed | Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. | 2.25e-07 | 2 | 17 | 2 | 15225124 | |
| Pubmed | Kendrin/pericentrin-B, a centrosome protein with homology to pericentrin that complexes with PCM-1. | 2.25e-07 | 2 | 17 | 2 | 11171385 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 14693722 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 27142583 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 24415753 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25258311 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12095988 | ||
| Pubmed | The CXXCXXC motif determines the folding, structure and stability of human Ero1-Lalpha. | 6.74e-07 | 3 | 17 | 2 | 10970843 | |
| Pubmed | Protein disulfide isomerase interacts with tau protein and inhibits its fibrillization. | 6.74e-07 | 3 | 17 | 2 | 24098548 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 15590633 | ||
| Pubmed | Novel missense MTTP gene mutations causing abetalipoproteinemia. | 1.35e-06 | 4 | 17 | 2 | 25108285 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 14500733 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 20152126 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 16291865 | ||
| Pubmed | Protein disulphide isomerase is required for signal peptide peptidase-mediated protein degradation. | 1.35e-06 | 4 | 17 | 2 | 19942855 | |
| Pubmed | Is protein disulfide isomerase a redox-dependent molecular chaperone? | 1.35e-06 | 4 | 17 | 2 | 12485997 | |
| Pubmed | The centriolar satellite protein Cep131 is important for genome stability. | 2.25e-06 | 5 | 17 | 2 | 22797915 | |
| Pubmed | Disulphide production by Ero1α-PDI relay is rapid and effectively regulated. | 3.37e-06 | 6 | 17 | 2 | 20802462 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 16677074 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 14592831 | ||
| Pubmed | Ccdc13 is a novel human centriolar satellite protein required for ciliogenesis and genome stability. | 3.37e-06 | 6 | 17 | 2 | 24816561 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 17301129 | ||
| Pubmed | Snapshot of the interaction between HIV envelope glycoprotein 120 and protein disulfide isomerase. | 4.72e-06 | 7 | 17 | 2 | 20458450 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 12218051 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 16632484 | ||
| Pubmed | Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection. | 4.72e-06 | 7 | 17 | 2 | 23206338 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 12218052 | ||
| Pubmed | Proteins of the PDI family: unpredicted non-ER locations and functions. | 6.29e-06 | 8 | 17 | 2 | 12384992 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 22031837 | ||
| Pubmed | Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. | 8.08e-06 | 9 | 17 | 2 | 17055437 | |
| Pubmed | 1.01e-05 | 10 | 17 | 2 | 25088364 | ||
| Pubmed | 1.18e-05 | 653 | 17 | 5 | 22586326 | ||
| Pubmed | 2.04e-05 | 14 | 17 | 2 | 12475965 | ||
| Pubmed | 2.69e-05 | 16 | 17 | 2 | 23245351 | ||
| Pubmed | 3.83e-05 | 19 | 17 | 2 | 24421332 | ||
| Pubmed | 7.81e-05 | 173 | 17 | 3 | 23979707 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.01e-04 | 1024 | 17 | 5 | 24711643 | |
| Pubmed | 1.02e-04 | 189 | 17 | 3 | 31594818 | ||
| Pubmed | 1.39e-04 | 210 | 17 | 3 | 16565220 | ||
| Pubmed | 1.48e-04 | 37 | 17 | 2 | 34225486 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.93e-04 | 235 | 17 | 3 | 30258100 | |
| Pubmed | 2.21e-04 | 246 | 17 | 3 | 15345747 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 2.90e-04 | 1284 | 17 | 5 | 17353931 | |
| Pubmed | 3.04e-04 | 1297 | 17 | 5 | 33545068 | ||
| Pubmed | 3.40e-04 | 285 | 17 | 3 | 32838362 | ||
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 3.41e-04 | 56 | 17 | 2 | 11076968 | |
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 3.53e-04 | 57 | 17 | 2 | 16462731 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 3.66e-04 | 58 | 17 | 2 | 12852856 | |
| Pubmed | 4.05e-04 | 61 | 17 | 2 | 7790358 | ||
| Pubmed | 4.74e-04 | 66 | 17 | 2 | 12221128 | ||
| GeneFamily | Protein disulfide isomerases | 2.95e-07 | 21 | 12 | 3 | 692 | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.12e-05 | 194 | 17 | 4 | 1316_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.26e-05 | 200 | 17 | 4 | 5931_DN | |
| Drug | BPD I | 2.87e-05 | 11 | 17 | 2 | CID000032348 | |
| Drug | Dithiol | 5.35e-05 | 100 | 17 | 3 | CID000010334 | |
| Drug | Leu-met | 6.26e-05 | 16 | 17 | 2 | CID000118276 | |
| Disease | Bipolar Disorder | 1.36e-04 | 477 | 17 | 4 | C0005586 | |
| Disease | Amyotrophic Lateral Sclerosis | 5.07e-04 | 58 | 17 | 2 | C0002736 | |
| Disease | Schizophrenia | 1.39e-03 | 883 | 17 | 4 | C0036341 | |
| Disease | seasonal gut microbiome measurement | 1.87e-03 | 112 | 17 | 2 | EFO_0007753 | |
| Disease | Major Depressive Disorder | 8.47e-03 | 243 | 17 | 2 | C1269683 | |
| Disease | asthma | 8.56e-03 | 751 | 17 | 3 | MONDO_0004979 | |
| Disease | Liver Cirrhosis, Experimental | 9.29e-03 | 774 | 17 | 3 | C0023893 | |
| Disease | Unipolar Depression | 9.57e-03 | 259 | 17 | 2 | C0041696 | |
| Disease | cleft lip | 1.14e-02 | 284 | 17 | 2 | EFO_0003959 | |
| Disease | apolipoprotein A 1 measurement | 1.19e-02 | 848 | 17 | 3 | EFO_0004614 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VATEKEFFFVKVFNT | 181 | O14862 | |
| EEFQKAQKVFEEFNV | 171 | P49418 | |
| GVKFFQRKVESFEEV | 156 | P14920 | |
| LTQQNDESKEFVKFF | 1631 | Q15154 | |
| FAEFAVQAEKKIEVV | 21 | O94915 | |
| KNFEQVAFDETKNVF | 396 | Q13087 | |
| NFEDVAFDEKKNVFV | 376 | P07237 | |
| FEKEFSFKNEETAQV | 1291 | O95613 | |
| FKNTVEIFKFEEAEN | 136 | Q15165 | |
| DDNFNKVVKFIFNTV | 2336 | Q99715 | |
| NFNVVVFDKEKDVFV | 396 | Q8N807 | |
| SFQEAAKFKELIFQV | 106 | Q99578 | |
| QVLTAVDKDNKFFFD | 1391 | P58107 | |
| EEVKKEVAFFNNFLT | 741 | Q9BXP5 | |
| FEDTFVNFQAAIEKK | 271 | Q9UIL8 | |
| KQFQEAIIVFQEEFK | 136 | P19075 | |
| TKKIFSENDIFEINF | 121 | Q8N7M2 |